Differences in Sterol Metabolites in Survivors of COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)
L.A. Leuenberger(The Ohio State University), Kymberly M. Gowdy(The Ohio State University Wexner Medical Center), Jeffrey C. Horowitz(Lung Institute), Samuel J. Cochran(The Ohio State University), Keri A. Tallman(Vanderbilt University), Michael B. Fessler(National Institutes of Health), Sonal Pannu(Oklahoma City University), H.-Y.H. Kim(Vanderbilt University), E. Schott(The Ohio State University), Ned A. Porter(Vanderbilt University), Joseph S. Bednash(The Ohio State University Wexner Medical Center)
Cited by 0
Related Papers
Extracellular matrix in lung development, homeostasis and disease
|Matrix Biology|2018|290
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
|American Journal of Respiratory and Critical Care Medicine|2013|247
Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor
|Journal of Biological Chemistry|2004|229
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
|New England Journal of Medicine|2022|181
Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis
|American Journal Of Pathology|2015|161